Variant report

Variant	nsv899054
Chromosome Location	chr12:47224325-47280079
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:166)
CpG islands
(count:856)
Chromatin interactive
region (count:11)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:166 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:47233922-47234185	HepG2	liver:	n/a	chr12:47234160-47234175
2	BACH1	chr12:47224764-47224897	H1-hESC	embryonic stem cell:	n/a	n/a
3	BATF	chr12:47257246-47257401	GM12878	blood:	n/a	n/a
4	BHLHE40	chr12:47233879-47234050	HepG2	liver:	n/a	n/a
5	BHLHE40	chr12:47233807-47234164	HepG2	liver:	n/a	n/a
6	CBX3	chr12:47249561-47249764	K562	blood:	n/a	n/a
7	CBX3	chr12:47270574-47271023	HCT-116	colon:	n/a	n/a
8	CEBPB	chr12:47268431-47268858	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr12:47277142-47277317	A549	lung:	n/a	n/a
10	CEBPB	chr12:47233903-47234211	IMR90	lung:	n/a	n/a
11	CEBPB	chr12:47233950-47234204	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr12:47233944-47234175	HepG2	liver:	n/a	n/a
13	CEBPB	chr12:47268441-47268894	ECC-1	luminal epithelium:	n/a	n/a
14	CEBPB	chr12:47252338-47252426	A549	lung:	n/a	n/a
15	CEBPB	chr12:47239930-47240130	HepG2	liver:	n/a	n/a
16	CEBPB	chr12:47233896-47234209	A549	lung:	n/a	n/a
17	CEBPB	chr12:47252219-47252533	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr12:47233868-47234241	HepG2	liver:	n/a	n/a
19	CEBPB	chr12:47233847-47234197	HepG2	liver:	n/a	n/a
20	CEBPB	chr12:47233831-47234193	MCF-7	breast:	n/a	n/a
21	CEBPB	chr12:47268503-47268862	ECC-1	luminal epithelium:	n/a	n/a
22	CEBPD	chr12:47233911-47234149	HepG2	liver:	n/a	n/a
23	CEBPZ	chr12:47226548-47226549	HepG2	liver:	n/a	n/a
24	CTCF	chr12:47251746-47251806	GM20000	blood:	n/a	n/a
25	CTCF	chr12:47260529-47260568	LNCaP	prostate:	n/a	n/a
26	CTCF	chr12:47270383-47270464	GM10248	blood:	n/a	n/a
27	CTCF	chr12:47237721-47237786	Lung_OC	lung:	n/a	n/a
28	CTCF	chr12:47272591-47272605	GM13976	blood:	n/a	n/a
29	CTCF	chr12:47268620-47268770	HPF	lung:	n/a	n/a
30	CTCF	chr12:47225540-47225690	HCPEpiC	choroid plexus:	n/a	n/a
31	CTCF	chr12:47225017-47225026	ProgFib	skin:	n/a	n/a
32	CTCF	chr12:47225120-47225270	AG09309	skin:	n/a	n/a
33	CTCF	chr12:47234060-47234210	Caco-2	colon:	n/a	n/a
34	E2F6	chr12:47224718-47226556	H1-hESC	embryonic stem cell:	n/a	chr12:47225642-47225652 chr12:47225645-47225654 chr12:47225544-47225553
35	E2F6	chr12:47224875-47226463	H1-hESC	embryonic stem cell:	n/a	chr12:47225642-47225652 chr12:47225645-47225654 chr12:47225544-47225553
36	EP300	chr12:47233805-47234268	HepG2	liver:	n/a	n/a
37	EP300	chr12:47237629-47238003	T-47D	breast:	n/a	n/a
38	EP300	chr12:47233804-47234182	HepG2	liver:	n/a	n/a
39	ESR1	chr12:47268288-47268695	ECC-1	luminal epithelium:	n/a	n/a
40	ESR1	chr12:47268238-47268716	ECC-1	luminal epithelium:	n/a	n/a
41	ESR1	chr12:47268275-47268818	ECC-1	luminal epithelium:	n/a	n/a
42	FOS	chr12:47257313-47257505	MCF10A-Er-Src	breast:	n/a	n/a
43	FOS	chr12:47233949-47234054	MCF10A-Er-Src	breast:	n/a	n/a
44	FOS	chr12:47257314-47257514	MCF10A-Er-Src	breast:	n/a	n/a
45	FOXA1	chr12:47233815-47234280	HepG2	liver:	n/a	chr12:47233979-47233994
46	FOXA1	chr12:47233823-47234272	HepG2	liver:	n/a	chr12:47233979-47233994
47	FOXA1	chr12:47233835-47234119	T-47D	breast:	n/a	chr12:47233979-47233994
48	FOXA1	chr12:47237677-47237984	T-47D	breast:	n/a	n/a
49	FOXA1	chr12:47233817-47234112	T-47D	breast:	n/a	chr12:47233979-47233994
50	FOXA1	chr12:47233732-47234191	HepG2	liver:	n/a	chr12:47233979-47233994

(count:856 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:47226255-47226305	HEK293	kidney:	embryo
2	chr12:47226301-47226351	LNCaP	prostate:	n/a
3	chr12:47226255-47226305	HEK293	kidney:	embryo
4	chr12:47226301-47226351	LNCaP	prostate:	n/a
5	chr12:47226005-47226055	CMK	blood:	n/a
6	chr12:47226255-47226305	NB4	blood:	n/a
7	chr12:47224954-47225004	MCF10A-Er-Src	breast:	n/a
8	chr12:47228121-47228171	AG09309	skin:	n/a
9	chr12:47225543-47225593	SAEC	small airway:	n/a
10	chr12:47225449-47225499	MCF10A-Er-Src	breast:	n/a
11	chr12:47228121-47228171	IMR90	lung:	fetal
12	chr12:47226029-47226079	MCF10A-Er-Src	breast:	n/a
13	chr12:47228121-47228171	HCT-116	colon:	n/a
14	chr12:47226301-47226351	Hela-S3	cervix:	n/a
15	chr12:47226005-47226055	IMR90	lung:	fetal
16	chr12:47228121-47228171	GM12892	blood:	n/a
17	chr12:47228121-47228171	HCPEpiC	choroid plexus:	n/a
18	chr12:47228121-47228171	GM06990	blood:	n/a
19	chr12:47226453-47226503	HEK293	kidney:	embryo
20	chr12:47225979-47226029	NB4	blood:	n/a
21	chr12:47224823-47224873	NHDF-neo	bronchial:	n/a
22	chr12:47226255-47226305	AoSMC	blood vessel:	n/a
23	chr12:47225543-47225593	GM12878	blood:	n/a
24	chr12:47226005-47226055	PANC-1	pancreas:	n/a
25	chr12:47224649-47224699	ovcar-3	ovarian:	n/a
26	chr12:47225543-47225593	NB4	blood:	n/a
27	chr12:47226453-47226503	HCF	heart:	n/a
28	chr12:47224954-47225004	SK-N-MC	brain:	n/a
29	chr12:47224954-47225004	LNCaP	prostate:	n/a
30	chr12:47225326-47225376	Hepatocyte	liver:	n/a
31	chr12:47226005-47226055	MCF10A-Er-Src	breast:	n/a
32	chr12:47226301-47226351	HCM	heart:	n/a
33	chr12:47226005-47226055	SK-N-SH_RA	brain:	n/a
34	chr12:47226255-47226305	SAEC	small airway:	n/a
35	chr12:47224649-47224699	SK-N-MC	brain:	n/a
36	chr12:47225449-47225499	NH-A	brain:	n/a
37	chr12:47233213-47233263	HEEpiC	esophagus:	n/a
38	chr12:47233213-47233263	Hela-S3	cervix:	n/a
39	chr12:47225979-47226029	BE2_C	brain:	n/a
40	chr12:47226029-47226079	H1-hESC	embryonic stem cell:	embryo
41	chr12:47226029-47226079	HepG2	liver:	n/a
42	chr12:47228121-47228171	RPTEC	kidney:	n/a
43	chr12:47225326-47225376	Caco-2	colon:	n/a
44	chr12:47224823-47224873	GM19239	blood:	n/a
45	chr12:47224954-47225004	SAEC	small airway:	n/a
46	chr12:47226255-47226305	NH-A	brain:	n/a
47	chr12:47233213-47233263	AG09309	skin:	n/a
48	chr12:47233213-47233263	NT2-D1	testis:	n/a
49	chr12:47224823-47224873	HCT-116	colon:	n/a
50	chr12:47225979-47226029	AG10803	skin:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:47223586..47226473-chr12:47229673..47232467,2	MCF-7	breast:
2	chr12:47230334..47232221-chr12:47235071..47236649,2	K562	blood:
3	chr12:47232992..47235990-chr12:47237722..47240632,2	K562	blood:
4	chr12:47266835..47268379-chr12:47268939..47270586,2	MCF-7	breast:
5	chr12:47232992..47235990-chr12:47237722..47240632,2	K562	blood:
6	chr12:47259078..47261834-chr12:47262406..47264893,2	MCF-7	breast:
7	chr12:47230334..47232221-chr12:47235071..47236649,2	K562	blood:
8	chr12:47266835..47268379-chr12:47268939..47270586,2	MCF-7	breast:
9	chr12:47221961..47224924-chr12:47229328..47232260,2	MCF-7	breast:
10	chr12:47221961..47224924-chr12:47229328..47232260,2	MCF-7	breast:
11	chr12:47259078..47261834-chr12:47262406..47264893,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM113B-5	chr12:47268597-47268830	XLOC_009725
2	lnc-FAM113B-5	chr12:47270358-47270578	XLOC_009725

No data

Variant related genes	Relation type
SLC38A4	TF binding region
SLC38A4	CpG island
ENSG00000139209	chromatin interactions

Extended variants
information (count: 1523 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:1523 , 50 per page) page: 1 2 3 4 5 6 7 ... 31

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs17684703	chr12:47224325-47224326	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs117831815	chr12:47224328-47224329	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs543466837	chr12:47224372-47224373	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs574180019	chr12:47224385-47224386	Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs542900098	chr12:47224409-47224410	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs576259966	chr12:47224429-47224430	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs78245144	chr12:47224434-47224435	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs527430712	chr12:47224440-47224441	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs376862121	chr12:47224513-47224514	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs192351255	chr12:47224523-47224524	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs180711480	chr12:47224547-47224548	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs549677352	chr12:47224588-47224589	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs370463567	chr12:47224614-47224615	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs569468849	chr12:47224635-47224636	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs535626542	chr12:47224716-47224717	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs548937210	chr12:47224743-47224744	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs566141890	chr12:47224747-47224748	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs534826435	chr12:47224748-47224749	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs558148059	chr12:47224749-47224750	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs149921923	chr12:47224777-47224778	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs560584990	chr12:47224778-47224779	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs4497488	chr12:47224788-47224789	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs74082913	chr12:47224799-47224800	Bivalent/Poised TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs574293850	chr12:47224823-47224824	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs543190884	chr12:47224824-47224825	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs553320035	chr12:47224870-47224871	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs572081068	chr12:47224884-47224885	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs540744376	chr12:47224900-47224901	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs186092234	chr12:47224901-47224902	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs114173163	chr12:47224941-47224942	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs543062857	chr12:47225025-47225026	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs563581644	chr12:47225035-47225036	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs370722117	chr12:47225062-47225063	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs4994910	chr12:47225071-47225072	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs549131394	chr12:47225124-47225125	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs565751114	chr12:47225135-47225136	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs74851348	chr12:47225196-47225197	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs149151746	chr12:47225204-47225205	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs571816455	chr12:47225229-47225230	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs191166226	chr12:47225257-47225258	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs112009300	chr12:47225295-47225296	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs377036861	chr12:47225318-47225319	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs61927432	chr12:47225395-47225396	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs536566416	chr12:47225427-47225428	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs375406663	chr12:47225428-47225429	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs531338123	chr12:47225499-47225500	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs370388521	chr12:47225514-47225515	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs532743638	chr12:47225526-47225527	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs573367678	chr12:47225558-47225559	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs540682190	chr12:47225574-47225575	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Hirschsprung''s Disease	21712996	CNVD
Lissencephaly	21572526	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	19602461	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Follicular lymphoma	20505157	CNVD
Hepatocellular carcinoma	16750200	CNVD
Melanoma	18172304	CNVD
Metanephric adenoma	20802469	CNVD
Glioblastoma multiforme	17387387	CNVD
liposarcomas	17372913	CNVD
Non-small cell lung cancer	24170126	CNVD
Cancer	16751803	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	16616336	CNVD
Intracranial aneurysm	16715129	CNVD
Breast cancer	17661082	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:359 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:47219800-47224400	Weak transcription	Right Ventricle	heart
2	chr12:47220000-47224600	Weak transcription	Pancreas	Pancrea
3	chr12:47220200-47224400	Weak transcription	Muscle Satellite Cultured Cells	--
4	chr12:47220200-47224400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr12:47220600-47224800	Weak transcription	HSMM	muscle
6	chr12:47224000-47224400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
7	chr12:47224000-47226400	Active TSS	Pancreatic Islets	Pancreatic Islet
8	chr12:47224200-47224400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
9	chr12:47224200-47224400	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
10	chr12:47224200-47224400	Enhancers	Breast Myoepithelial Primary Cells	Breast
11	chr12:47224200-47224400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
12	chr12:47224200-47224400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr12:47224200-47224400	Enhancers	NHEK	skin
14	chr12:47224200-47224600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr12:47224200-47224600	Enhancers	Esophagus	oesophagus
16	chr12:47224200-47224800	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
17	chr12:47224200-47225000	Flanking Active TSS	Liver	Liver
18	chr12:47224200-47225200	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
19	chr12:47224200-47225200	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
20	chr12:47224200-47225800	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr12:47224200-47226000	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr12:47224200-47226400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
23	chr12:47224200-47226400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
24	chr12:47224400-47224600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr12:47224400-47224600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
26	chr12:47224400-47224600	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr12:47224400-47224600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
28	chr12:47224400-47224600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr12:47224400-47224600	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
30	chr12:47224400-47224600	Active TSS	Muscle Satellite Cultured Cells	--
31	chr12:47224400-47224600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr12:47224400-47224600	Bivalent Enhancer	Colonic Mucosa	Colon
33	chr12:47224400-47224600	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
34	chr12:47224400-47224600	Enhancers	Left Ventricle	heart
35	chr12:47224400-47224600	Flanking Active TSS	Psoas Muscle	Psoas
36	chr12:47224400-47224600	Enhancers	Right Ventricle	heart
37	chr12:47224400-47224800	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
38	chr12:47224400-47224800	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
39	chr12:47224400-47224800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
40	chr12:47224400-47224800	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
41	chr12:47224400-47224800	Bivalent Enhancer	Primary T cells from cord blood	blood
42	chr12:47224400-47224800	Bivalent/Poised TSS	Thymus	Thymus
43	chr12:47224400-47224800	Bivalent Enhancer	HMEC	breast
44	chr12:47224400-47224800	Bivalent Enhancer	Osteobl	bone
45	chr12:47224400-47225000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr12:47224400-47225000	Bivalent Enhancer	Fetal Thymus	thymus
47	chr12:47224400-47225000	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
48	chr12:47224400-47225000	Flanking Active TSS	NHEK	skin
49	chr12:47224400-47225600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
50	chr12:47224400-47225600	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links